.Pharmacolibrary.Drugs.ATC.R.R05DA09_1 .Pharmacolibrary.Drugs.ATC.R.R05DA09_1| name: | Dextromethorphan_1 |
| ATC code: | R05DA09_1 | route: | oral |
| n-compartments | 1 |
Dextromethorphan is a cough suppressant used for symptomatic relief of dry irritating cough. It is commonly available over-the-counter and is approved for use in many countries.
Pharmacokinetics in adult CYP2D6 poor metabolizers following oral administration.
Abduljalil, K, et al., & Fuhr, U (2010). Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan. Clinical pharmacology and therapeutics 88(5) 643–651. DOI:10.1038/clpt.2010.137 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20881950
Nagai, N, et al., & Ogata, H (1996). Pharmacokinetics and polymorphic oxidation of dextromethorphan in a Japanese population. Biopharmaceutics & drug disposition 17(5) 421–433. DOI:10.1002/(SICI)1099-081X(199607)17:5<421::AID-BDD421>3.0.CO;2-9 PUBMED:https://pubmed.ncbi.nlm.nih.gov/8830977
Marasanapalle, VP, et al., & Zack, J (2024). Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D6*17 and CYP2D6*29, When Compared with Normal Metabolizers. Journal of clinical pharmacology 64(5) 578–589. DOI:10.1002/jcph.2366 PUBMED:https://pubmed.ncbi.nlm.nih.gov/37803948